Back Bay Serves as Exclusive Advisor to Centrexion on Licensing Agreement with Lilly [Back Bay Transaction] Investment Banking UpdateInvestment Banking TeamJanuary 9, 2020Transactions
Integrating Patient Reported Outcomes BlogBack Bay Life Science AdvisorsJanuary 2, 2020Clinical and Regulatory Affairs
Artificial Intelligence and Drug Discovery Insights, BlogBack Bay Life Science AdvisorsJanuary 1, 2020AI, Drug Development
STAT NEWS: Microbiome Drug Development a Rapidly Evolving Field Insights, Back Bay in the News, Life Science MediaBack Bay Life Science AdvisorsNovember 13, 2019Microbiome, Drug Development
STAT: Early Price Setting, Other Market Access Planning is Key for Early-Stage Drug, Device Companies Back Bay in the News, Life Science MediaChristopher Leo, PhD October 29, 2019Drug Pricing, Market Access, Emerging BioPharma, Emerging Companies
The Disappearance of Chinese Capital in US Biotechnology BlogBack Bay Life Science AdvisorsSeptember 5, 2019Biotech Financing
Changing the Game: Digital Solutions in Healthcare BlogBack Bay Life Science AdvisorsJune 19, 2019Digital Healthcare
